Medicon Hellas S.A. Logo

Medicon Hellas S.A.

Develops, makes, and sells IVD products, analytical systems & software for healthcare providers.

MEDIC | AT

Overview

Corporate Details

ISIN(s):
GRS424003002
LEI:
21380029I4NIQ9ZXE146
Country:
Greece
Address:
MELITONA 5-7, 15344 GERAKAS
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Medicon Hellas S.A. is a leading company in the in-vitro diagnostics (IVD) sector. Its operations encompass the research, development, manufacturing, and sale of proprietary IVD products, including diagnostic reagent kits and bulk materials. The company also imports and distributes automated analytical systems from international manufacturers and develops specialized software for laboratory and medical applications. It serves a broad range of healthcare providers, such as public and private hospitals, clinical labs, and diagnostic centers. Products are exported globally through a network of distributors as both branded items and materials for further processing. The company's activities also include providing diagnostic services and manufacturing a line of cosmetics and personal care products. Medicon Hellas operates under key quality certifications, including ISO 13485, and a manufacturer’s license from the National Medicines Organization.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-29 19:30
Interim Report
Οικονομική έκθεση MEDICON ΕΛΛΑΣ A.E (2025,Εξαμηνιαία,Ενοποιημένη)
Greek (modern) 1.8 MB
2025-06-26 09:11
Notice of Dividend Amount
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΓΝΩΣΤΟΠΟΙΗΣΗ ΑΠΟΚΟΠΗΣ ΔΙΚΑΙΩΜΑΤΟΣ ΜΕΡΙΣΜΑΤΟΣ / ΠΛΗΡΩΜΗΣ ΜΕΡΙΣΜΑΤ…
Greek (modern) 800.1 KB
2025-06-26 09:10
Declaration of Voting Results & Voting Rights Announcements
ΟΡΘΗ ΕΠΑΝΑΛΗΨΗ-ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Greek (modern) 518.3 KB
2025-06-25 16:42
Declaration of Voting Results & Voting Rights Announcements
ΑΝΑΚΟΙΝΩΣΗ ΓΙΑ ΤΙΣ ΑΠΟΦΑΣΕΙΣ ΓΕΝΙΚΗΣ ΣΥΝΕΛΕΥΣΗΣ
Greek (modern) 518.2 KB
2025-05-30 11:14
Pre-Annual General Meeting Information
INVITATION FOR THE ANNUAL GENERAL MEETING 2025
English 490.8 KB

Automate Your Workflow. Get a real-time feed of all Medicon Hellas S.A. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medicon Hellas S.A.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Medicon Hellas S.A. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Cantourage Group SE Logo
A European platform producing and distributing medical cannabis products to pharmacies.
Germany HIGH
CAREGEN CO.,LTD. Logo
Develops patented peptides and growth factors for medical aesthetics, pharma, and anti-aging markets.
South Korea 214370
CELADON PHARMACEUTICALS PLC Logo
Vertically integrated pharma developing cannabis medicines for chronic pain.
United Kingdom CEL
Celemics, Inc. Logo
Develops custom NGS panels and bioinformatics for research and clinical diagnostics.
South Korea 331920
Develops & manufactures radiopharmaceuticals for cancer diagnosis and therapy.
South Korea 308430
CELL BIOTECH CO ., LTD Logo
A global biotech firm offering probiotic raw materials, OEM/ODM services, and consumer brands.
South Korea 049960
Cellectis Logo
Develops 'off-the-shelf' CAR T-cell cancer immunotherapies using TALEN® gene-editing.
France ALCLS
Cellid Co., Ltd. Logo
Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.
South Korea 299660

Talk to a Data Expert

Have a question? We'll get back to you promptly.